257 related articles for article (PubMed ID: 30021819)
1. Cost of Dialysis Therapy by Modality in Manitoba.
Beaudry A; Ferguson TW; Rigatto C; Tangri N; Dumanski S; Komenda P
Clin J Am Soc Nephrol; 2018 Aug; 13(8):1197-1203. PubMed ID: 30021819
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of dialysis therapies.
Klarenbach S; Manns B
Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
[TBL] [Abstract][Full Text] [Related]
3. Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis.
Wang V; Coffman CJ; Sanders LL; Lee SD; Hirth RA; Maciejewski ML
Clin J Am Soc Nephrol; 2018 Dec; 13(12):1833-1841. PubMed ID: 30455323
[TBL] [Abstract][Full Text] [Related]
4. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
[TBL] [Abstract][Full Text] [Related]
5. The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.
Rodríguez-Carmona A; Perez Fontán M; Bouza P; García Falcón T; Valdés F
Adv Perit Dial; 1996; 12():93-6. PubMed ID: 8865880
[TBL] [Abstract][Full Text] [Related]
6. [Cost of dialysis in France].
Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
[TBL] [Abstract][Full Text] [Related]
7. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
[TBL] [Abstract][Full Text] [Related]
8. Cost of the quanta SC+ hemodialysis system for self-care in the United Kingdom.
Ferguson TW; Harper GD; Milad JE; Komenda PVJ
Hemodial Int; 2022 Jul; 26(3):287-294. PubMed ID: 35001500
[TBL] [Abstract][Full Text] [Related]
9. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
[TBL] [Abstract][Full Text] [Related]
10. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada.
McFarlane PA
Semin Dial; 2004; 17(2):118-24. PubMed ID: 15043613
[TBL] [Abstract][Full Text] [Related]
11. Hidden Costs Associated with Conversion from Peritoneal Dialysis to Hemodialysis.
Weinhandl ED; Saffer TL; Aragon M
Kidney360; 2022 May; 3(5):883-890. PubMed ID: 36128476
[TBL] [Abstract][Full Text] [Related]
12. Health economic evaluations: the special case of end-stage renal disease treatment.
Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS
Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484
[TBL] [Abstract][Full Text] [Related]
13. An operating cost comparison between conventional and home quotidian hemodialysis.
Kroeker A; Clark WF; Heidenheim AP; Kuenzig L; Leitch R; Meyette M; Muirhead N; Ryan H; Welch R; White S; Lindsay RM
Am J Kidney Dis; 2003 Jul; 42(1 Suppl):49-55. PubMed ID: 12830444
[TBL] [Abstract][Full Text] [Related]
14. The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis.
Liu FX; Treharne C; Culleton B; Crowe L; Arici M
BMC Nephrol; 2014 Oct; 15():161. PubMed ID: 25278356
[TBL] [Abstract][Full Text] [Related]
15. Costs of Assisted Home Dialysis: A Single-Payer Canadian Model From Manitoba.
Bamforth RJ; Beaudry A; Ferguson TW; Rigatto C; Tangri N; Bohm C; Komenda P
Kidney Med; 2021; 3(6):942-950.e1. PubMed ID: 34939003
[TBL] [Abstract][Full Text] [Related]
16. An Economic Assessment Model of Rural and Remote Satellite Hemodialysis Units.
Ferguson TW; Zacharias J; Walker SR; Collister D; Rigatto C; Tangri N; Komenda P
PLoS One; 2015; 10(8):e0135587. PubMed ID: 26284357
[TBL] [Abstract][Full Text] [Related]
17. An economic evaluation of hospital-based hemodialysis and home-based peritoneal dialysis for pediatric patients.
Coyte PC; Young LG; Tipper BL; Mitchell VM; Stoffman PR; Willumsen J; Geary DF
Am J Kidney Dis; 1996 Apr; 27(4):557-65. PubMed ID: 8678067
[TBL] [Abstract][Full Text] [Related]
18. The financial implications for Medicare of greater use of peritoneal dialysis.
Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
[TBL] [Abstract][Full Text] [Related]
19. Variation in Peritoneal Dialysis Time on Therapy by Country: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study.
Lambie M; Zhao J; McCullough K; Davies SJ; Kawanishi H; Johnson DW; Sloand JA; Sanabria M; Kanjanabuch T; Kim YL; Shen JI; Pisoni RL; Robinson BM; Perl J;
Clin J Am Soc Nephrol; 2022 Jun; 17(6):861-871. PubMed ID: 35641246
[TBL] [Abstract][Full Text] [Related]
20. Changing the paradigm from contraction of peritoneal dialysis programs to increasing prevalent peritoneal dialysis numbers.
Cross J; Davenport A
Adv Perit Dial; 2013; 29():50-4. PubMed ID: 24344492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
